+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Novo Nordisk A/S - logo

Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. Key products include diabetes care medications and devices. Novo Nordisk is also involved with hemostasis management, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 40,000 employees in 75 countries, and markets its products in more than 180 countries.

Hormone Replacement Therapy Market 2024-2028 - Product Thumbnail Image

Hormone Replacement Therapy Market 2024-2028

  • Report
  • January 2024
  • 161 Pages
  • Global
From
Digital Diabetes Management Market Report 2025 - Product Thumbnail Image

Digital Diabetes Management Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
Diabetes Care Devices Market Report 2025 - Product Thumbnail Image

Diabetes Care Devices Market Report 2025

  • Report
  • March 2025
  • 400 Pages
  • Global
From
From
From
Human Insulin - Global Strategic Business Report - Product Thumbnail Image

Human Insulin - Global Strategic Business Report

  • Report
  • April 2025
  • 94 Pages
  • Global
From
From
From
From
Oral Biologics & Biosimilar Drugs Market Report 2025 - Product Thumbnail Image

Oral Biologics & Biosimilar Drugs Market Report 2025

  • Report
  • April 2025
  • 250 Pages
  • Global
From
From
From
From
From
Loading Indicator